Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1995-1999  (2)
  • 1925-1929
  • 1840-1849
  • Brain injury  (1)
  • Head and neck cancer  (1)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Intensive care medicine 25 (1999), S. 722-728 
    ISSN: 1432-1238
    Keywords: Key words Somatosensory evoked potentials ; Brain injury ; Outcome ; Outcome prediction ; Health state measure
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective: To evaluate the outcome of children 1 and 5 years after severe brain injury (Glasgow Coma Score 〈 8) using a functional measure [Glasgow Outcome Scale (GOS)] and a health status measure (the Torrance Health State (HUI:1)) and to determine the ability of somatosensory evoked potentials (SEPs) to predict these long-term outcomes. Design: Prospective study. Setting: A 16-bed paediatric intensive care unit in a tertiary children's hospital. Patients and participants: 105 children with severe brain injury. Interventions: SEPs were recorded once in the first week after admission. Outcome was assessed 1 and 5 years after injury using the GOS and at 5 years after injury using HUI:1. Measurements and results: At 5 years, using the GOS, 46 (43.8 %) children had a good outcome, 10 (9.5 %) were moderately disabled, 2 (1.9 %) severely disabled, 3 (2.9 %) vegetative and 44 (41.9 %) had died. At 5 years, 17 of 40 (42.5 %) survivors from 1 year had changed outcomes: 12 had improved, 3 had worsened and 2 had died. For a normal SEP, positive predictive power was 85.4 %, sensitivity 62.5 %, specificity 87.8 %, negative predictive power 67.2 % and the positive likelihood ratio was 5.1. For bilaterally absent responses, positive predictive power was 90.9 %, sensitivity 61.2 %, specificity 94.6 %, negative predictive power 73.6 % and the positive likelihood ratio was 11.4. Outcomes using HUI:1 were: 30 (28.6 %) had a good quality of life, 21 (20.0 %) had a moderate quality of life, 7 (6.7 %) a poor quality, 44 died (41.9 %) and 3 (2.9 %) survived in a state deemed worse than death. For a normal SEP, positive predictive power was 85.4 %, sensitivity 68.6 %, specificity 88.9 %, negative predictive power 75.0 % and the positive likelihood ratio was 6.2. For bilaterally absent responses, positive predictive power was 93.9 %, sensitivity 57.4 %, specificity 96.1 %, negative predictive power 68.1 % and the positive likelihood ratio was 14.6. Conclusion: The outcome for children with severe brain injury should be assessed 5 years after injury because important changes occur between 1 year and 5 years. Differences exist between outcomes assessed using the GOS and HUI:1 as they measure slightly different aspects of function. Consideration should therefore be given to using both measures. SEPs are excellent predictors of long-term outcome measured by either the GOS or the HUI:1.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Lasers in medical science 11 (1996), S. 23-29 
    ISSN: 1435-604X
    Keywords: Photodynamic therapy ; Head and neck cancer ; Chlorin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine , Physics , Technology
    Notes: Abstract Over the past 30 months, the authors have treated a wide variety of head and neck cancer patients with meta-tetrahydroxyphenylchlorin (mTHPC)-mediated photodynamic therapy (PDT). This drug is a powerful, second-generation photosensitizer with significant advantages over earlier drugs. Treatment ranged from palliation and adjunctive to curative procedures. Results to date are very encouraging, with marked advantages over standard methods of treatment with respect to morbidity, both functional and aesthetic. Potential cure rates remain essentially unchanged, very much dependent on the stage of the tumour. These promising early results justify a multicentre study for treatment of early head and neck cancer using this drug and light combination. This is now underway.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...